Hans P. Maerki

Difluoroketamide derivatives as HTRA1 inhibitors

Difluoroketamide derivatives as HtrA1 inhibitors

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

Difluoroketamide derivatives as HtrA1 inhibitors

Difluoroketamide derivatives

Trifluoromethylpropanamide derivatives

Dihydroquinoline pyrazolyl compounds

Pyridinyloxy- and phenyloxy-pyrazolyl compounds

Dihydroquinoline pyrazolyl compounds

Dihydroquinoline pyrazolyl compounds

Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors

Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

Dihydroquinoline-2-one derivatives

Dihydroquinoline-2-one derivatives

NEW BIARYL AMIDE DERIVATIVES

Imidazolylketone derivatives

Phenyl-tetrahydroisoquinoline derivatives

Bicyclic dihydroisoquinoline-1-one derivatives

Bicyclic dihydroquinoline-2-one derivatives

Dihydroquinoline-2-one derivatives

Aryl-benzocycloalkyl amide derivatives

Biaryl amide derivatives

Heterocyclyl compounds

Bicyclic compounds

Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists

Heterocyclyl compounds

Heterocyclyl compounds

Heteroaryl carboxamide derivatives

Biaryl derivatives

Pyrazol derivatives

Heterocyclic compounds

Imidazole derivatives

Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists